Search research articles
Contact Us
Filters
Showing results (321-330 of 361) with videos related to
Page
of 37
Sort By:
Diabetologia
|
September 16, 2011
A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3
K Hess, S H Alzahrani, M Mathai, et al.
ACS Biomaterials Science & Engineering
|
September 23, 2021
Nonresonant CARS Imaging of Porous and Solid Silicon Nanoparticles in Human Cells
Maxim B Gongalsky, Daniela A Muftieva, Jukka K S Saarinen, et al.
Diabetes Care
|
January 26, 2010
Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study
Rebecca M Reynolds, Mark W J Strachan, Javier Labad, et al.
Molecular Pharmaceutics
|
November 2, 2017
Probing Pharmaceutical Mixtures during Milling: The Potency of Low-Frequency Raman Spectroscopy in Identifying Disorder
Greg Walker, Philipp Römann, Bettina Poller, et al.
BMC Endocrine Disorders
|
December 17, 2008
The Edinburgh Type 2 Diabetes Study: study protocol
Jackie F Price, Rebecca M Reynolds, Rory J Mitchell, et al.
Diabetologia
|
December 17, 2009
Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
J Labad, J F Price, M W J Strachan, et al.
Human Molecular Genetics
|
March 4, 2010
Variation in the uric acid transporter gene (SLC2A9) and memory performance
Lorna M Houlihan, Niki D Wyatt, Sarah E Harris, et al.
Journal of Hypertension
|
March 16, 2013
Metabolic parameters associated with arterial stiffness in older adults with Type 2 diabetes: the Edinburgh Type 2 diabetes study
Wei Leng Teoh, Jackie F Price, Rachel M Williamson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 19, 2013
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study
Joanne R Morling, Jonathan A Fallowfield, Rachel M Williamson, et al.
Diabetes Care
|
April 12, 2011
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
Rachel M Williamson, Jackie F Price, Stephen Glancy, et al.
Page
of 37
Search research articles
Search
Showing results (321-330 of 361) with videos related to
Sort By:
Page
of 37
Diabetologia
|
September 16, 2011
A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3
K Hess, S H Alzahrani, M Mathai, et al.
ACS Biomaterials Science & Engineering
|
September 23, 2021
Nonresonant CARS Imaging of Porous and Solid Silicon Nanoparticles in Human Cells
Maxim B Gongalsky, Daniela A Muftieva, Jukka K S Saarinen, et al.
Diabetes Care
|
January 26, 2010
Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study
Rebecca M Reynolds, Mark W J Strachan, Javier Labad, et al.
Molecular Pharmaceutics
|
November 2, 2017
Probing Pharmaceutical Mixtures during Milling: The Potency of Low-Frequency Raman Spectroscopy in Identifying Disorder
Greg Walker, Philipp Römann, Bettina Poller, et al.
BMC Endocrine Disorders
|
December 17, 2008
The Edinburgh Type 2 Diabetes Study: study protocol
Jackie F Price, Rebecca M Reynolds, Rory J Mitchell, et al.
Diabetologia
|
December 17, 2009
Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
J Labad, J F Price, M W J Strachan, et al.
Human Molecular Genetics
|
March 4, 2010
Variation in the uric acid transporter gene (SLC2A9) and memory performance
Lorna M Houlihan, Niki D Wyatt, Sarah E Harris, et al.
Journal of Hypertension
|
March 16, 2013
Metabolic parameters associated with arterial stiffness in older adults with Type 2 diabetes: the Edinburgh Type 2 diabetes study
Wei Leng Teoh, Jackie F Price, Rachel M Williamson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 19, 2013
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study
Joanne R Morling, Jonathan A Fallowfield, Rachel M Williamson, et al.
Diabetes Care
|
April 12, 2011
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
Rachel M Williamson, Jackie F Price, Stephen Glancy, et al.
Page
of 37